This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.

The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
 Therapeutic Area
 Oncological Disorders
 Infectious Diseases
 Neurological Disorders
 Immunological Disorders
 Endocrine Disorders
 Cardiovascular Disorders
 Respiratory Disorders
 Ophthalmic Disorders
 Musculoskeletal Disorders
 Inflammatory Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 Aegicare
 Aiforia Technologies
 Ardigen
 Berg
 Google
 Huawei
 Merative
 Nference
 NVIDIA
 Owkin
 Phenomic AI
 Pixel AI

Table of Contents

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY

5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS

6. COMPANY PROFILES

7. PORTER’S FIVE FORCES ANALYSIS

8. CLINICAL TRIAL ANALYSIS

9. FUNDING AND INVESTMENT ANALYSIS

10. START-UP HEALTH INDEXING

11. COMPANY VALUATION ANALYSIS

12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY

13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS

14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

15. CONCLUDING REMARKS

16. INTERVIEW TRANSCRIPTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html

Learn from experts: do you know about these emerging industry trends?
Key Trends in Non-Viral Transfection Market
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]